Pfizer Press Statements Archive
Adverse Event Reporting
Clinical Trials
Pfizer's Collaboration with Healthcare Professionals and Clinical Investigators
- February 9, 2009 — Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators
- Frequently Asked Questions
Additional Press Statements
- January 22, 2009 — Pfizer Inc today issued the following statement on the proposed Physician Sunshine Act
- May 29, 2008 — A message about Chantix® (varenicline) from Pfizer
- May 8, 2008 — Testimony before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations
Statement of James T. Sage, Senior Director/Team Leader, Lipitor®, Pfizer Inc - February 8, 2008 — Pfizer Response To Initial, Non-Final Office Action by US Patent And Trademark Office
Intellectual Property and American Competitiveness
- August 13, 2008 — Letter from Jeff Kindler Chairman and CEO, Pfizer Inc, to The Honorable Max Baucus, Chairman, Finance Committee, United States Senate
- July 15, 2008 — Testimony of Jeff Kindler Chairman and CEO, Pfizer Inc, before the Senate Finance Committee on International Enforcement of Intellectual Property Rights and American Competitiveness
Trovan / Nigeria Clinical Study
- January 30, 2009 — Pfizer Responds to Divided Ruling by U.S. Court of Appeals for 2nd Circuit in Cases Related to Trovan Study in Nigeria
- July 31, 2007 — Pfizer Files Challenge to Improper Nigerian Government Report in Trovan Cases
- Trovan Fact Sheet
- Trovan Statement of Defense Summary
- Trovan Litigation, Statement of Defense
- May 29, 2007 — Pfizer Statement on Trovan
Food Safety
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
Stock Symbol: PFE Stock Exchange: NYSE
Stock Quote at: Sep 3 2010 4:00PM
| Last 16.46 | Change 0.06 |
| %Change | 0.37 | Vol. | 33,124,845 |
| Day High | 16.59 | 52 Wk. High | 20.36 |
| Day Low | 16.38 | 52 Wk. Low | 14.00 |
| Open | 16.47 | Mkt. Cap(Bil) | 132.31 |
| Prev. Close | 16.40 |
Our press kit provides information that might help you write stories or simply find out more about Pfizer.
Access Pfizer images and videos including product logos, headshots, and video clips.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
